Chester County News and Community Website
CHESTER SPRINGS, PA — Affinity Bio Partners recently announced its expansion into India. The company states it intends on opening offices in the near future. The CRO which focuses heavily on …
Affinity Bio Partners Expands Its Operations Into India Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has provided an update on the status of certain of its clinical programs and on its research and development (R&D) operations.
Aclaris Therapeutics Provides R&D Update Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently reported positive results following the completion of a toxicology and pharmacokinetic study designed to support clinical trials with Epoladerm™, one of …
Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (NASDAQ: ABUS), X-Chem, Inc. (X-Chem) and Proteros biostructures GmbH (Proteros) announced this week that Arbutus Biopharma has identified several molecules that inhibit the SARS-CoV-2 …
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. announced that the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) recently awarded research and development contracts to …
Virpax Advances Envelta Development with NCATS Under CRADA Agreement Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep disorder that …
FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment Read More
CHEYNEY, PA — Navrogen, Inc. announced this week that it has raised $3.0M from equity financing to support its Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities.
Navrogen Closes $3.0M Seed Financing To Advance Its Preclinical Pipeline Read More
EXTON, PA — Frontage Laboratories, Inc. this week announced that it has completed construction of a new 71,000 square foot laboratory facility located at 760 Pennsylvania Drive in Exton, Pennsylvania.
Frontage Opens a New State-of-the-Art Laboratory Facility in Exton, PA Read More
WASHINGTON, D.C. — The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in …
FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced positive preliminary topline results from its first in …
Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 Read More